For decades, Japanese scientists have known about the immune-modulating potential of arabinoxylan from rice bran. Yet because of its large molecular structure, arabinoxylan is difficult to absorb, so its potential lay dormant. In 1992, Japanese scientists developed a highly bioavailable low-molecular weight arabinoxylan, called rice bran arabinoxylan compound (RBAC). Founded in 2007, the Institute for Progressive Research of RBAC Immunomodulator Compounds (iPraxic) is dedicated to disseminating objective, scientific educational information on rice bran arabinoxylan compound (RBAC). As a health care practitioner looking to improve the health and quality of life of your patients, RBAC is worthy of your attention.

Our mission at iPraxic is to educate consumers, patients, and their health professionals about the immuno-modulating properties of RBAC, with the ultimate goal of helping people across the planet lead healthier, happier lives. That mission is reflected in our name. The word “praxis” means “translating an idea into action, as distinguished from theory.” By educating the public about RBAC, iPraxic is making the idea of better health a reality.